Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bupropion: new therapy for depression.

M Feinberg1

  • 1Hahnemann University School of Medicine, Philadelphia, Pennsylvania.

American Family Physician
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Bupropion, a recently approved antidepressant, shows satisfactory antidepressant action compared to placebo. Its long-term effects are not well established, suggesting discontinuation after several months of therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A qualitative study of adaptation challenges of Ukrainian refugees in the United States.

Children and youth services review·2025
Same author

Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.

International journal of STD & AIDS·2018
Same author

Sources of bias in Gorman critique of bias: again a need for more reasonable, valid conclusions with true dialogue.

Psychological medicine·2017
Same author

Preference of certain scolytidae for different conifers : A statistical approach.

Journal of chemical ecology·2014
Same author

Psychopathology and pathological gambling among males: Theoretical and clinical concerns.

Journal of gambling studies·2013
Same author

Rationale and methods of the European Food Consumption Validation (EFCOVAL) Project.

European journal of clinical nutrition·2011
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Medicine

Background:

  • Bupropion represents a novel antidepressant with a distinct chemical structure compared to traditional tricyclic antidepressants.
  • The precise mechanism of action for bupropion's antidepressant effects remains largely unknown.
  • While bupropion weakly inhibits dopamine reuptake, this action is not considered the primary driver of its therapeutic efficacy.

Purpose of the Study:

  • To evaluate the efficacy of bupropion as an antidepressant treatment.
  • To compare bupropion's antidepressant effects against a placebo in clinical trials.
  • To assess the safety and tolerability profile of bupropion.

Main Methods:

  • Clinical trials were conducted to assess bupropion's effectiveness.

Related Experiment Videos

  • Patient outcomes were compared between groups receiving bupropion and those receiving a placebo.
  • Data on adverse events and therapeutic response were collected and analyzed.

    • Main Results:

    • Bupropion demonstrated satisfactory antidepressant action when compared to placebo in clinical trials.
    • The drug's efficacy suggests a viable therapeutic option for depression.
    • No definitive mechanism explaining the antidepressant effects was identified, despite weak dopamine reuptake inhibition.

    Conclusions:

    • Bupropion is an effective antidepressant compared to placebo.
    • The long-term effects and safety profile of bupropion require further investigation.
    • Discontinuation of bupropion therapy after several months is recommended due to uncertainties regarding long-term use.